Petriev V M, Vatin A E, Prusova R M, Filatov P P, Khachirov D G
Antibiotiki. 1982 Aug;27(8):623-6.
Pharmacokinetics of 57Co-bleomycetin was studied on mice with lymphosarcoma LIO-1. It was found that at early periods of intravenous administration of the labeled antibiotic, i.e. within the period from 5 minutes to 1 hour its higher levels are detected in the liver, kidneys, blood serum, lungs, intestine and tumor. At later periods the drug levels in the organs and tissues gradually decrease and by the 72nd hour the concentration of 57Co-bleomycetin in the blood serum appears to be 30 times lower as that after 5 minutes. In the muscles and tumor its concentrations by that period are 15 and 2 times lower respectively. Radiometry of the animals showed that within the first 24 hours more than 85 per cent of 57Co-bleomycetin was excreted from the mice.
对患有淋巴肉瘤LIO - 1的小鼠研究了57钴 - 博来霉素的药代动力学。结果发现,在静脉注射标记抗生素后的早期,即在5分钟至1小时内,在肝脏、肾脏、血清、肺、肠道和肿瘤中检测到其含量较高。在后期,器官和组织中的药物水平逐渐下降,到第72小时,血清中57钴 - 博来霉素的浓度似乎比5分钟后低30倍。到那时,肌肉和肿瘤中的浓度分别低15倍和2倍。对动物的放射性测定表明,在最初的24小时内,超过85%的57钴 - 博来霉素从小鼠体内排出。